<code id='920EA9377A'></code><style id='920EA9377A'></style>
    • <acronym id='920EA9377A'></acronym>
      <center id='920EA9377A'><center id='920EA9377A'><tfoot id='920EA9377A'></tfoot></center><abbr id='920EA9377A'><dir id='920EA9377A'><tfoot id='920EA9377A'></tfoot><noframes id='920EA9377A'>

    • <optgroup id='920EA9377A'><strike id='920EA9377A'><sup id='920EA9377A'></sup></strike><code id='920EA9377A'></code></optgroup>
        1. <b id='920EA9377A'><label id='920EA9377A'><select id='920EA9377A'><dt id='920EA9377A'><span id='920EA9377A'></span></dt></select></label></b><u id='920EA9377A'></u>
          <i id='920EA9377A'><strike id='920EA9377A'><tt id='920EA9377A'><pre id='920EA9377A'></pre></tt></strike></i>

          leisure time

          leisure time

          author:comprehensive    Page View:1

          What does Covid-19 have in store for the winter? When are good data not good enough? And how many would-be Wegovys are there?

          We cover all that and more this week on “The Readout LOUD,” STAT’s biotech podcast. Our colleague Helen Branswell joins us to discuss the state of the Covid-19 pandemic heading into the fall and the rollout of boosters shots aimed at the latest viral variants. We also discuss the latest news in the life sciences, including an IPO implosion, a debate at the FDA, and the ups and downs of a career in biotech.

          advertisement

          For more on what we cover, here’s the latest on booster shots; here’s more on Covid-19 in 2023; here’s the news on Alnylam Pharmaceuticals; here’s more on 2Seventy Bio; here’s where you can find episodes of Color Code; and here’s where you can subscribe to the First Opinion Podcast.

          Be sure to sign up on Apple Podcasts, Spotify, Stitcher, TuneIn, or wherever you get your podcasts.

          And if you have any feedback for us — topics to cover, guests to invite, vocal tics to cease — you can email [email protected].

          advertisement

          focus

          Novavax promises a turnaround & Lilly roils the obesity market
          Novavax promises a turnaround & Lilly roils the obesity market

          SammyKimballforSTATCanNovavaxfinallygetitright?What’sa“triple-G”drug?AndisNovoNordisklosingground?We

          read more
          How a Boston hospital is priming medical residents to use GPT
          How a Boston hospital is priming medical residents to use GPT

          MedicalresidentsatBethIsraelDeaconessMedicalCenteruseGPT-4astheytrytodiagnoseadiseaseinaJulyworkshop

          read more
          Jerome Adams on the need for new antivirals for Covid
          Jerome Adams on the need for new antivirals for Covid

          PaxlovidtabletsamplesbeinginspectedinFreiburg,Germany.PfizerviaAPTheU.S.Covid-19Public HealthEmergen

          read more

          Hormonal contraceptives don’t actually treat endometriosis

          AdobeAt14,afternearlythreeyearsofhauntingthelocalurgentcareclinicbecauseofmyintensemenstrualperiods,